The Biolocity team is pleased to share that graduate company, Guide Therapeutics, a developer of nonviral drug delivery vehicles for genetic medicines, was acquired by Beam Therapeutics in February of 2021. Details on their merger are available here.
Guide Therapeutics Principle Investigator, Dr. James Dahlman, participated in the Biolocity Launch program in 2019 receiving project management and business mentorship to assist in completing commercialization milestones for his GuideTX technology. We are thrilled about his recent success and company acquisition!
“As a scientist without formal business training, I had no idea how to speak with Venture Capitalists or create an appropriate pitch deck. The Biolocity team helped me learn these valuable skills.”
– James Dahlman, PhD Assistant Professor, Department of Biomedical Engineering, Georgia Institute of Technology & Emory School of Medicine